All News about Edesa Biotech Inc
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Edesa Biotech Reports Fiscal Third Quarter 2023 Results
August 09, 2023
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/06/28/edsa.png?width=1200&height=800&fit=crop)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://cdn.benzinga.com/files/images/story/2023/01/17/edesa_logo-home-100px.jpg?width=1200&height=800&fit=crop)
Edesa Biotech's Dermatitis Study Data Fails To Cheer Investors
January 17, 2023
Via Benzinga
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Edesa Biotech Appoints Biotech Deal Veteran to CFO Role
June 27, 2023
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Edesa Biotech to Participate in Swiss Biotech Day
April 20, 2023
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Edesa Biotech Reports Fiscal 1st Quarter 2023 Results
February 10, 2023
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Edesa Biotech Receives Regulatory Approval for Phase 2 Vitiligo Study
February 01, 2023
Via ACCESSWIRE
![](https://cdn.benzinga.com/files/images/story/2023/01/18/image45.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/17/image38_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/17/image9.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/17/image21.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/17/image15.jpg?width=1200&height=800&fit=crop)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Edesa Biotech Reports Topline Phase 2b Results for Dermatology Drug
January 17, 2023
Via ACCESSWIRE
![](https://cdn.benzinga.com/files/images/story/2022/12/23/image40.jpg?width=1200&height=800&fit=crop)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
FDA Grants Fast Track to Edesa Biotech's ARDS Drug Candidate
December 20, 2022
Via ACCESSWIRE
![](https://cdn.benzinga.com/files/images/story/2022/12/22/image20.jpeg?width=1200&height=800&fit=crop)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Edesa Biotech Reports Fiscal Year 2022 Results
December 16, 2022
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://cdn.benzinga.com/files/images/story/2022/10/03/image_1.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/11/shutterstock_1667119063.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.